{"id":"https://openalex.org/W2107939830","doi":"https://doi.org/10.2217/imt.11.29","title":"Immunotherapy of Hepatocellular Carcinoma: Is there a Place for Regulatory T-Lymphocyte Depletion?","display_name":"Immunotherapy of Hepatocellular Carcinoma: Is there a Place for Regulatory T-Lymphocyte Depletion?","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2107939830","doi":"https://doi.org/10.2217/imt.11.29","mag":"2107939830","pmid":"https://pubmed.ncbi.nlm.nih.gov/21524167"},"language":"en","primary_location":{"id":"doi:10.2217/imt.11.29","doi":"https://doi.org/10.2217/imt.11.29","is_oa":false,"landing_page_url":"https://doi.org/10.2217/imt.11.29","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001379085","display_name":"Jeannette Cany","orcid":"https://orcid.org/0000-0002-5214-639X","observed_orcids":["https://orcid.org/0000-0002-5214-639X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jeannette Cany","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108210052","display_name":"Lucile Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lucile Tran","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012547336","display_name":"Vanessa Gauttier","orcid":"https://orcid.org/0000-0002-4297-0449","observed_orcids":["https://orcid.org/0000-0002-4297-0449"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vanessa Gauttier","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085435908","display_name":"Jean\u2010Paul Judor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Paul Judor","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010005979","display_name":"Georges Vassaux","orcid":"https://orcid.org/0000-0002-1149-7716","observed_orcids":["https://orcid.org/0000-0002-1149-7716"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Georges Vassaux","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nicolas Ferry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Ferry","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018875160","display_name":"Sophie Conchon","orcid":"https://orcid.org/0000-0003-2602-3385","observed_orcids":["https://orcid.org/0000-0003-2602-3385"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Conchon","raw_affiliation_strings":["INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U948, Bioth\u00e9rapies H\u00e9patiques, CHU Hotel Dieu, Nantes, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":null,"apc_paid":null,"fwci":1.3022,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.80083833,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"3","issue":"sup4","first_page":"32","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.156700000166893,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1404000073671341,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":1.0},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.8759999871253967},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7329999804496765},{"id":"https://openalex.org/keywords/antigen-specific-immunotherapy","display_name":"antigen-specific immunotherapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":0.9670000076293945},{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.7739999890327454},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.5189999938011169},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.7929999828338623},{"id":"https://openalex.org/keywords/cancer-recurrence-prevention","display_name":"tumor recurrence prevention","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8028903603553772},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7250651717185974},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4857645332813263},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48572593927383423},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44147875905036926},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.436599999666214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33002614974975586},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18127226829528809}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004052","descriptor_name":"Diethylnitrosamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2217/imt.11.29","doi":"https://doi.org/10.2217/imt.11.29","is_oa":false,"landing_page_url":"https://doi.org/10.2217/imt.11.29","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},{"id":"pmid:21524167","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21524167","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/95993","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/95993","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Immunotherapy, 3, 4 Suppl, pp. 32-4","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/95993","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/95993","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Immunotherapy, 3, 32 - 4","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1993211204","https://openalex.org/W2000066381","https://openalex.org/W2008451487","https://openalex.org/W2009378591","https://openalex.org/W2020207615","https://openalex.org/W2021416992","https://openalex.org/W2035638191","https://openalex.org/W2039257775","https://openalex.org/W2044422127","https://openalex.org/W2053526872","https://openalex.org/W2066143990","https://openalex.org/W2099657378","https://openalex.org/W2105187541","https://openalex.org/W2111616718","https://openalex.org/W2113030185","https://openalex.org/W2115906750","https://openalex.org/W2122656254","https://openalex.org/W2147771351"],"related_works":["https://openalex.org/W2119942216","https://openalex.org/W2052329251","https://openalex.org/W2044422127","https://openalex.org/W3029719661","https://openalex.org/W2360360388","https://openalex.org/W2060872878","https://openalex.org/W2401998188","https://openalex.org/W2064630742","https://openalex.org/W2615658229","https://openalex.org/W2347427093"],"abstract_inverted_index":{"Immunotherapy":[0],"represents":[1],"a":[2,24,44,80,128,154],"potential":[3,58],"therapeutic":[4],"option":[5],"for":[6],"patients":[7],"with":[8,79,159],"hepatocellular":[9],"carcinoma":[10],"(HCC),":[11],"especially":[12],"as":[13],"secondary":[14],"treatment":[15],"to":[16,30,96,127],"prevent":[17],"recurrence.":[18],"It":[19],"has":[20],"been":[21],"shown":[22],"that":[23,40],"patient's":[25],"survival":[26],"is":[27],"directly":[28],"correlated":[29],"the":[31,48,52,57,102],"type":[32],"and":[33,75,94,125,136],"number":[34],"of":[35,51,59,66,77,91,101,108,114,156],"tumor-infiltrating":[36],"immune":[37,41],"cells,":[38],"indicating":[39],"responses":[42,168],"have":[43,55],"direct":[45],"effect":[46],"on":[47,87,120],"clinical":[49,149,167],"course":[50],"disease.":[53],"We":[54],"assessed":[56],"immunotherapy":[60,135,162],"against":[61,131],"HCC":[62,123,145,170],"in":[63,142,169],"preclinical":[64,146],"models":[65],"low":[67],"tumor":[68,103,132],"burden.":[69,104],"An":[70],"antigen-specific":[71,161],"strategy":[72],"targeting":[73],"\u03b1-fetoprotein,":[74],"consisting":[76],"immunization":[78],"DNA-based":[81],"synthetic":[82],"vector":[83],"(DNAmAFP/704),":[84],"was":[85,117],"tested":[86,119],"an":[88,97,121,160],"autochthonous":[89],"model":[90,124],"chemical":[92],"hepatocarcinogenesis":[93],"led":[95,126],"important":[98],"(65%)":[99],"reduction":[100],"A":[105],"nonspecific":[106],"approach":[107],"CD25(+)":[109],"T-cell":[110],"depletion":[111,138,158],"by":[112],"injection":[113],"PC61":[115],"antibody":[116],"also":[118,164],"orthotopic":[122],"significant":[129],"protection":[130],"development.":[133],"Antigen-specific":[134],"Treg":[137,157],"are":[139],"promising":[140],"strategies":[141],"physiologically":[143],"relevant":[144],"models.":[147],"Future":[148],"trials":[150],"will":[151,163],"demonstrate":[152],"if":[153],"combination":[155],"translate":[165],"into":[166],"patients.":[171]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}